175
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study

ORCID Icon, , , , ORCID Icon, , & ORCID Icon show all
Pages 2761-2772 | Received 23 Aug 2023, Accepted 26 Oct 2023, Published online: 01 Nov 2023

References

  • Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PLoS One. 2012;7(7):7. doi:10.1371/journal.pone.0039803
  • Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62(2):2. doi:10.2332/allergolint.13-RAI-0564
  • Konstantinou GN, Konstantinou GN, Koulias C, Petalas K, Makris M. Further understanding of neuro-immune interactions in allergy: implications in pathophysiology and role in disease progression. J Asthma Allergy. 2022;15:1273–1291. doi:10.2147/JAA.S282039
  • Gaspar NK, Aidé MK. Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol. 2016;91(4):479–488. doi:10.1590/abd1806-4841.20164211
  • Lambrechts L, Gilissen L, Morren M. Topical corticosteroid phobia among healthcare professionals using the TOPICOP score. Acta Derm Venereol. 2019;99(11):1004–1008. doi:10.2340/00015555-3220
  • El Hachem M, Gesualdo F, Ricci G, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017;43(1):22. doi:10.1186/s13052-017-0330-7
  • Stalder JF, Aubert H, Anthoine E, et al. Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score. Allergy Eur J Allergy Clin Immunol. 2017;72(11):1713–1719. doi:10.1111/all.13189
  • Aubert‐Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808–814. doi:10.1111/j.1365-2133.2011.10449.x
  • Fatani MI, Al Sheikh AA, Alajlan MA, et al. National Saudi Consensus statement on the management of atopic dermatitis (2021). Dermatol Ther. 2022;12(7):1551–1575. doi:10.1007/s13555-022-00762-6
  • Alakeel A, Al Sheikh A, Alraddadi AA, et al. Management of atopic dermatitis in adults in Saudi Arabia: consensus recommendations from the Dermatological Expert Group. Clin Cosmet Investig Dermatol. 2022;15:1435–1445.
  • Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931–936. doi:10.1046/j.1365-2133.2000.03473.x
  • Saito-Abe M, Futamura M, Yamamoto‐Hanada K, Yang L, Suzuki K, Ohya Y. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: a cross-sectional study using TOPICOP in Japan. Pediatr Dermatol. 2019;36(3):311–316. doi:10.1111/pde.13784
  • Bos B, Antonescu I, Osinga H, Veenje S, Jong K, Vries TW. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers. Pediatr Dermatol. 2019;36(1):100–104. doi:10.1111/pde.13698
  • Mueller SM, Itin P, Vogt DR, et al. Assessment of “corticophobia” as an indicator of non‐adherence to topical corticosteroids: a pilot study. J Dermatolog Treat. 2017;28(2):104‐111. doi:10.1080/09546634.2016.1201189
  • Chin HW, Jang HS, Jang BS, et al. A study on utilization of alternative medicine for patients with atopic dermatitis. Korean J Dermatol. 2005;43(7):903–911.
  • Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013;8(10):e76493. doi:10.1371/journal.pone.0076493
  • Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211‐216. doi:10.1016/j.jaad.2006.05.073
  • Smith SD, Hong E, Fearns S, Blaszczynski A, Fischer G. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol. 2010;51(3):168‐174. doi:10.1111/j.1440-0960.2010.00636.x
  • Lee JY, Her Y, Kim CW, et al. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015;27(5):499‐506. doi:10.5021/ad.2015.27.5.499
  • Gustavsen HE, Gjersvik P. Topical corticosteroid phobia among par- ents of children with atopic dermatitis in a semirural area of Norway. J EurAcad Dermatol Venereol. 2016;30(1):168. doi:10.1111/jdv.12670
  • Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis a systematic review. JAMA Dermatol. 2017;153(10):1036‐ 1042. doi:10.1001/jamadermatol.2017.2437
  • Hon KL, Kam WY, Leung TF, et al. Steroid fears in children with eczema. Acta Paediatr. 2006;95(11):11. doi:10.1080/08035250600612298
  • Fischer G. Compliance problems in paediatric atopic eczema. Australas J Dermatol. 1996;37(Suppl 1):S10–S13. doi:10.1111/j.1440-0960.1996.tb01070.x
  • Faught J, Bierl C, Barton B, Kemp A. Stress in mothers of young children with eczema. Arch Dis Child. 2007;92(8):683–686. PMID: 17412743; PMCID: PMC2083902. doi:10.1136/adc.2006.112268
  • Datta D, Sarkar R, Podder I. Parental stress and quality of life in chronic childhood dermatoses: a review. J Clin Aesthet Dermatol. 2021;14(9 Suppl 1):S19–S23.
  • Chernyshov PV, Ho RC, Monti F, et al. Gender differences in self-assessed health-related quality of life in children with atopic dermatitis. J Clin Aesthet Dermatol. 2016;9(8):19–24.
  • Gerner T, Haugaard JH, Vestergaard C, et al. Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia. Pediatr Allergy Immunol. 2021;32(2):331–341. doi:10.1111/pai.13394